AbbVie Inc (MEX:ABBV)
MXN 3585.03 38.93 (1.1%) Market Cap: 6.16 Tn Enterprise Value: 7.46 Tn PE Ratio: 61.23 PB Ratio: 51.65 GF Score: 75/100

Abbvie Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 05:50PM GMT
Release Date Price: MXN3160.92 (-1.23%)
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Well, good afternoon, and welcome to the AbbVie session of Cowen's 42nd Annual Healthcare Conference. We're very, very pleased to have the company back with us again this year.

Representing the company are 3 members of senior management: Mike Severino, who is Vice Chairman and President; Rob Michael, who is Vice Chairman, Finance and Commercial Operations and Chief Financial Officer; and Jeff Stewart, who is the Executive Vice President and Chief Commercial Officer.

There's always lots of ground to cover with AbbVie given a multitude of growth drivers, which seem to be delivering simultaneously. So let's dig right in, and I'll start it out with a look into the future.

Questions & Answers

Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So we're all obviously aware of the Humira patent expiration that's upcoming. But thereafter, it looks like a pretty vibrant second half to the decade

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot